about
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients.Cervical cancer: incidence and survival in migrants within Spain.Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families.Mammographic density and breast cancer in women from high risk families.Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibininEstimating long-term crude probability of death among young breast cancer patients: a Bayesian approach.Identification of a founder BRCA1 mutation in the Moroccan population.Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic?BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.Paraneoplastic limbic encephalitis in a male with squamous cell carcinoma of the lung.[The impact of cancer in Catalonia. Introduction][Cancer survival trends in Catalonia and comparison with Europe]Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study.Identification of a new complex rearrangement affecting exon 20 of BRCA1.Predicting the cancer burden in Catalonia between 2015 and 2025: the challenge of cancer management in the elderly.[WebSurvCa: web-based estimation of death and survival probabilities in a cohort].[Proportion of breast cancer in women aged 50 to 69 years from Girona, Spain, according to detection method].Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian models.[Time trend of breast cancer incidence in Catalonia].Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona-Tarragona 1985-2004).Cancer incidence in AIDS patients in Catalonia, Spain.ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study.Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancerSocioeconomic differences in cervical cancer: two case-control studies in Colombia and SpainIncidencia poblacional de las neoplasias linfoides según el subtipo histológico (Clasificación de la OMS) en Girona, 1994-2001Probabilidad de desarrollar y morir por cáncer en Cataluña en el período 1998-2001Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbineInvestigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNANeuroendocrine tumors: A population-based study of incidence and survival in Girona province, 1994–2004Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013)Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patientsPhase II trial of chemotherapy with cisplatin and etoposide in non-small cell lung cancer[Sources of information about cancer][Perception of the causes of cancer and its prevention in women of Girona]Phase II trial of carboplatin in combination with etoposide in locally advanced large cell carcinoma and adenocarcinoma of the lung[The risk of breast cancer in Catalonia][Breast cancer and heredity: results of a population case-control study in Girona]
P50
Q33214386-98A84435-1CF2-4CD6-AC98-24E4A1B02A73Q33702944-3A636494-89EA-4767-A452-529C7E4103EEQ34188457-A918EC11-E1D3-4A90-BD50-50CC58FD2BDEQ35842576-104CF393-1538-42EA-B36B-A92160907D2EQ37362587-5CAF6BB2-72C0-474A-A59F-CA4AC9FF7C87Q39372610-C6D6FC35-437E-4293-BE31-38030157825AQ39375023-D60C47F4-BB05-4FF2-90FA-BFECBBA128C9Q39891022-F88FCF82-59B9-4006-AB2C-9088E03E08E8Q40886401-47628E26-2079-454E-9286-42AAA9F84338Q42472069-6B0EEF15-88F1-440C-BEEF-FB8CA621329AQ43729388-09607FB7-8ADF-4788-BB49-88FE74EA3305Q44848643-1A7D9DB5-797B-4342-85BB-8D91317CA015Q44923978-5C689FF6-E173-4F41-8733-5D994C08743FQ45906926-DAEA31D3-5104-49F0-BB40-ED6BECCD59F4Q47805949-E8DB4FDE-E3FF-4CE2-A74A-B6FD439EA00BQ50091895-55C8A6A6-AB05-41B4-AA80-BD2704258237Q50481600-F57BFB76-471B-4AE8-8963-4FF905A7C505Q50744592-7643BB37-6BFC-49D6-9E91-4844DF4D3FE7Q50778522-A6503EAE-26A8-493A-888F-1104A66E9E36Q51179375-110C7CFF-5247-4EF0-9F75-05EBB075E5B6Q51485443-0C713BE5-6FEC-4A1F-8B7A-53D06B3D76BAQ51743631-9CC4CAE0-8B80-490F-BDE6-C222C1DCC860Q51762592-FBF8E459-AE2B-41A0-814F-FD0F3CFB2AEBQ52586113-95132DA4-1674-4C13-A14C-44286EE7AD5CQ54765466-908C17CB-B8B7-4F46-B4F4-A71889D86209Q57252123-DA29A0BD-1778-4800-B12D-40C9695907E6Q57252125-F412101B-E45C-414C-9C8C-7272D630159EQ58053657-06AA4979-72C1-4ED9-A097-A81CBE148B30Q58053674-C1B3F409-5E8C-47CD-9057-5A033ECB5EECQ59274140-2476C8F2-74D1-414C-8AC4-5028EE4E7239Q59312459-DBEA4E5A-4596-415E-8E5C-746E36891C71Q59312500-B24E4591-7BB7-42DA-8EAE-063FAB357124Q64120013-BBC44A7E-6D53-4FE8-A97D-AB18E0230B6FQ67903007-3D12064A-4FA0-4B44-A918-02D65529AE85Q69508938-BD2DAC69-15B6-4A81-B878-7FD5DBF198D7Q70801817-B6BE89FA-8BDE-4EB5-A43F-5F56BF65EBAAQ71264224-91F95F9D-6963-425E-822D-E0105DB50B75Q72012076-FD51A16E-5A58-4D9C-8CB0-38472447D58AQ73099546-DA046B27-0647-411B-ACE9-12119E71EBE7Q74498790-58167F26-CFB2-4E41-9A98-CADAAEF94306
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
A Izquierdo
@ast
A Izquierdo
@en
A Izquierdo
@es
A Izquierdo
@nl
type
label
A Izquierdo
@ast
A Izquierdo
@en
A Izquierdo
@es
A Izquierdo
@nl
prefLabel
A Izquierdo
@ast
A Izquierdo
@en
A Izquierdo
@es
A Izquierdo
@nl
P31
P496
0000-0003-2004-3246